Vaccine-breakthrough infection by the SARS-CoV-2 omicron variant elicits broadly cross-reactive immune responses.

ABSTRACT:

SUBMITTER: Zhou R 

PROVIDER: S-EPMC8792449 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature